Maternal thyroid hormone status in pre-eclampsia: a tertiary care hospital based study


  • Sonali Deshpande Department of Obstetrics & Gynaecology, GMC, Aurangabad, Maharashtra, India
  • Kanan Yelikar Department of Obstetrics & Gynaecology, GMC, Aurangabad, Maharashtra, India
  • Shreyas Patil Department of Obstetrics & Gynaecology, GMC, Aurangabad, Maharashtra, India
  • Smita Andurkar Department of Preventive & Social Medicine, GMC, Aurangabad, Maharashtra, India



Pre-eclampsia, Thyroid Hormone status, TSH


Background: The objective of the study was to study the association between thyroid hormone status with preeclampsia and correlate it with severity of pre-eclampsia.

Methods: In this case control study, 200 women attending tertiary care hospital between the study period September 2012 to August 2014 were recruited in the study in which 100 women were cases (diagnosed as preeclampsia) and 100 were taken as control (healthy normotensive women). Assessment of thyroid status of cases and control was done. Association was studied between thyroid hormone status and pre-eclampsia and co-related with severity of preeclampsia.

Results: There was a significant association between pre-eclampsia and thyroid hypofunction (overt and sub clinical hypothyroidism) with P-value being 0.0406. Odds-ratio indicates that preeclampsia group have chance of higher TSH (>4.8 mIU/L) by 2.19 times. (95% confidence intervals= 1.0223 –4.6934). The association between severity of pre-eclampsia and thyroid hypofunction (subclinical and overt hypothyroidism) was found to be statistically significant (p= 0.02717). Odds ratio indicates that severe preeclampsia group have 2.87 times more chance of thyroid hypofunction.

Conclusions: In the present study a positive association was found between thyroid hypofunction and pre-eclampsia and it was found to be statistically significant. With regards to the results of the present study, “the measurement of serum levels of FT3, FT4 and TSH” can be suggested as a criterion for prediction of pre-eclampsia.


Negro R, Farmoso G, Mangieri T. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab. 2006;91:2587-91.

Dutta DC. Hypertensive disorders in pregnancy. In Text book of Obstetrics including perinatology and contraception. 6th edition, Calcutta: New central book agency. 2004:221-42.

Borst GC, Eil C, Burman KD. Euthyroid hyperthyroxinemia. Ann Intern Med. Mar 1983;98(3):366-78.

Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R. Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and Postpartum. Thyroid. 2011;21(10):1081–125.

Gary CF, Leveno KJ, Bloom SC, Hauth JC, Gilstrap L, Wenstrom KD. Pregnancy Hypertension, ln Williams Obstetrics 23rd Edn. New York Meltrawya. 2005:706-714.

Dhananjaya BS, Sendil Kumaran D, Venkatesh G, Niranjan M, Shashiraj HK. Thyroid Stimulating Hormone (TSH) levels as a Possible Indicator of Pre-eclampsia, Journal of Clinical and Diagnostic Research. 2011;5(8):1542-3.

Qublan HS, Al Laisi IJ, Hindawi IM, Hiasat MS, Awamleh I, Hamaideh AH, et al. severe preeclampsia and maternal thyroid function. J Obstet Gynecol. 2003;23:244-6.

Khadem N, Ayatollahi H, Roodsari FV, Ayati S. Comparison of serum levels of Tri-iodothyroxineT3, Thyroxine T4 and Thyroid- Stimulating Hormone(TSH) in pre-eclampsia and normal pregnancy, Iranian Journal of Reproductive Medicine. 2010;10(1):47-52.

Mostaghel N, Tavanayanfar E, Samani EN. Association of Maternal Hypothyroidism with Pre-eclampsia Iranian Journal of Pathology. 2008;3(2):51-4.






Original Research Articles